Article

A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature

2024-04-01

Abstract excerpt

In this report we describe the case of a healthy, young, athletic woman who developed acute lymphoblastic leukaemia (ALL)/lymphoblastic lymphoma (LBL) after receiving the second dose of the Pfizer/BioNTech modified mRNA (modRNA) COVID-19 genetic vaccine (marketed as Comirnaty®). The first dose of the genetic vaccine did not appear to illicit any noticeable side effects, but within 24 hours of the second dose t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ab364c71-91c1-5316-9c32-ac0d9f5eaf5d
DOI: 10.20944/preprints202403.1661.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing LiteratureDOI 10.20944/preprints202403.1661.v2Read

Acute myeloid leukemia superimposed on hemophagocytic lymphohistiocytosis after COVID19 vaccinationSemantic proximity Read

The case of T-ALL presenting with NK phenotype after COVID-19 vaccination.Semantic proximity Read

Major rise of a chronic lymphoid leukemia clone during the course of COVID-19.Semantic proximity Read

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesSemantic proximity Read

Coley`s Toxin to first Approved Therapeutic Vaccine - a Brief Historical Account in the Progression of Immunobiology Based Cancer TreatmentSemantic proximity Read

Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia.Semantic proximity Read

RNA-loaded nanoparticles for the treatment of hematological cancersSemantic proximity Read

Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trialSemantic proximity Read

Consensus on COVID-19 vaccination in pediatric oncohematological patients, on behalf of infectious working group of Italian Association of Pediatric Hematology OncologySemantic proximity Read

B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case reportSemantic proximity Read

Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical TrialSemantic proximity Read

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccinesSemantic proximity Read